Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

CUSIP: 89422G107

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
92,930,114
Total 13F shares
82,734,245
Share change
-5,140,965
Total reported value
$1,157,476,987
Put/Call ratio
116%
Price per share
$13.99
Number of holders
175
Value change
-$64,293,173
Number of buys
88
Number of sells
80

Security key

89422G107

Report period

Q3 2024

Institutions

175

Top holders

10

Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
8.2%
7,644,789
$62,840,164 30 Jun 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
8.1%
7,500,000
$61,650,000 30 Jun 2024
13F
Deep Track Capital, LP
13F
Company
7.9%
7,370,000
$60,581,400 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
7.1%
6,619,756
$54,414,394 30 Jun 2024
13F
Rock Springs Capital Management LP
13F
Company
4.8%
4,482,265
$36,844,218 30 Jun 2024
13F
MACQUARIE GROUP LTD
13F
Company
4.7%
4,367,830
$35,904,000 30 Jun 2024
13F
STATE STREET CORP
13F
Company
3.8%
3,510,677
$28,857,765 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
3.8%
3,489,662
$28,685,021 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.2%
2,949,335
$24,243,534 30 Jun 2024
13F
Assenagon Asset Management S.A.
13F
Company
2.4%
2,214,099
$18,199,894 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.4%
2,203,814
$18,115,351 30 Jun 2024
13F
Kynam Capital Management, LP
13F
Company
2.2%
2,021,659
$16,618,037 30 Jun 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
2%
1,889,844
$15,534,518 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
2%
1,878,954
$15,445,002 30 Jun 2024
13F
Finepoint Capital LP
13F
Company
1.9%
1,776,728
$14,604,704 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,666,301
$13,699,973 30 Jun 2024
13F
EMERALD ADVISERS, LLC
13F
Company
1.8%
1,637,146
$13,457,340 30 Jun 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
1.6%
1,533,072
$12,601,852 30 Jun 2024
13F
Woodline Partners LP
13F
Company
1.4%
1,276,878
$10,495,937 30 Jun 2024
13F
Eversept Partners, LP
13F
Company
1.2%
1,091,165
$8,969,376 30 Jun 2024
13F
Pictet Asset Management Holding SA
13F
Company
1.1%
977,954
$8,038,782 30 Jun 2024
13F
Parkman Healthcare Partners LLC
13F
Company
1%
969,892
$7,972,512 30 Jun 2024
13F
DEUTSCHE BANK AG\
13F
Company
1%
946,601
$7,781,060 30 Jun 2024
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
1%
941,265
$7,737,198 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.85%
785,295
$6,455,125 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.84%
778,649
$6,400,495 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.79%
737,638
$6,063,384 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.76%
704,562
$5,791,500 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.69%
640,309
$5,263,340 30 Jun 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.68%
634,401
$5,214,776 30 Jun 2024
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
0.66%
615,000
$5,055,300 30 Jun 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.65%
602,108
$4,949,327 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.61%
568,593
$4,673,834 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.6%
553,300
$4,548,126 30 Jun 2024
13F
GW&K Investment Management, LLC
13F
Company
0.55%
510,126
$4,193,000 30 Jun 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.51%
472,396
$3,883,095 30 Jun 2024
13F
Exome Asset Management LLC
13F
Company
0.48%
443,379
$3,644,575 30 Jun 2024
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.47%
435,641
$3,580,969 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.44%
409,857
$3,369,024 30 Jun 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.43%
400,000
$3,288,000 30 Jun 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.37%
346,068
$2,844,681 30 Jun 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.34%
320,580
$2,635,164 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.34%
314,180
$2,582,560 30 Jun 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.3%
279,104
$2,294,235 30 Jun 2024
13F
Walleye Capital LLC
13F
Company
0.29%
266,471
$2,190,392 30 Jun 2024
13F
David M. Knott Jr.
13F
Individual
0.29%
265,966
$2,186,000 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.28%
264,816
$2,176,788 30 Jun 2024
13F
PDT Partners, LLC
13F
Company
0.26%
238,783
$1,962,796 30 Jun 2024
13F
HighVista Strategies LLC
13F
Company
0.24%
219,416
$1,803,600 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.2%
186,312
$1,531,485 30 Jun 2024
13F

Institutional Holders of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) as of Q3 2024

As of 30 Sep 2024, Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,734,245 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock, Inc., VANGUARD GROUP INC, Rock Springs Capital Management LP, Woodline Partners LP, MACQUARIE GROUP LTD, STATE STREET CORP, EMERALD ADVISERS, LLC, RENAISSANCE TECHNOLOGIES LLC, and D. E. Shaw & Co., Inc.. This page lists 175 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
168
Q3 2024 holders
175
Holder diff
7
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .